GPC3 and breast cancer: In addition, GPC3 has been shown to selectively inhibit proliferation and induce apoptosis in certain breast cancer cells and mesothelioma cells by interacting with Wnt5a to trigger non-canonical Wnt/JNK signaling and concomitantly suppress canonical Wnt/β-catenin signaling [13,44].